Home » Newsletters » BioWorld Science

BioWorld Science

April 22, 2002

View Archived Issues

Dose-dependent improvement on rotigotine CDS in Parkinson's patients

Altocor filed for European marketing approval

Name change for inhalation technology company

Novel therapy to reduce or eliminate insulin dependence proves effective in NOD mice

Compounds with anticonvulsant activity prepared and tested at Arzneimittelwerk Dresden

Lead Androgenics compound blocks androgen receptor activation at an early step

CKD-732 examined for pharmacokinetic and metabolic profile in vitro and in vivo

All four components of PHY-906 necessary for biological activity as chemotherapy adjuvant

Small-molecule inhibitors of FAH designed at Bayer as potential agents for NSCLC

Small-molecule GnRH antagonist with good oral bioavailability presented at AACR meeting

Takeda presents new orally active antitumor agent for HER2-positive cancers

CTLA4-Ig cleared to enter phase I/II trial in ITP

Phase III trial of Affinitac in combination with Gemzar/cisplatin in NSCLC

Aquavan completes phase I study, safely achieves loss of consciousness

Ampligen evaluated in two new HIV/AIDS trials

Patient enrollment completed in phase II trial of interferon omega in chronic hepatitis C

Tularik presents first-quarter 2002 results

Broad-spectrum antimicrobial agents described by Chiron

Oxazolidinones patented by Abbott for bacterial infections, etc.

Tricyclic protein farnesyltransferase inhibitors with antiproliferative activity

New Chiron compounds reportedly useful for angiogenesis-related conditions

Roche designs new p38 kinase inhibitors

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...